Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eziclen/Izinova in paediatric colonoscopy
NCT03008460Phase 3Completed
- Sponsor
- Ipsen
- Start
- Oct 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 6
01
Overview
Phase 3, randomised, single-blind trial of sodium sulfate + potassium sulfate + magnesium sulfate in bowel preparation (2 arms), sponsored by Ipsen. Primary endpoint: Percentage of Subjects With Successful Overall Colon Preparation, Assessed With the Cleansing Score at Day 2. Started Oct 2017; status: completed.
02
Drugs
sodium sulfate + potassium sulfate + magnesium sulfate
03
Conditions
bowel preparation
Beyond the preview
Go deeper on NCT03008460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03008460.